Moody National Bank Trust Division Novo Cure LTD Transaction History

Moody National Bank Trust Division

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 22, 2019	SELL	$42.22 - $63.23 $3,715 - $5,564	-88 Closed	0 $0
Q1 2019 Apr 11, 2019	SELL	$31.96 - $56.12 $1,438 - $2,525	-45 Reduced 33.83%	88 $4,000
Q4 2018 Jan 07, 2019	BUY	$28.72 - $52.63 $3,819 - $6,999	133 New	133 $4,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.69B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

Stay updated on Moody National Bank Trust Division with notifications on news.